Scinovex
Subscribe
Health Sciences → Medicine → Genetics

Chronic Lymphocytic Leukemia Research

This cluster of papers focuses on the genomic aberrations, treatment strategies, and prognostic factors associated with chronic lymphocytic leukemia (CLL). It covers topics such as the use of BTK inhibitors (e.g., Ibrutinib), the role of rituximab, TP53 mutations, and the impact of immunoglobulin mutations. Additionally, it explores therapeutic targets and outcomes in patients with Waldenström macroglobulinemia.

99.4K works worldwide1.2M citations
Chronic Lymphocytic LeukemiaGenomic AberrationsBTK InhibitorsRituximabIbrutinibPrognostic FactorsTP53 MutationWaldenström MacroglobulinemiaImmunoglobulin MutationTherapeutic Targets

Journals publishing in this area

Articles on Scinovex in this research area

1 articles, most cited first

  1. Unveiling the protective potential: Naringenin's role in mitigating methotrexate induced hematological alterations
    International Journal of Advanced Biochemistry Research · 2025 · 0 citations